Is 4D Molecular Therapeutics Inc (FDMT) Stock worth its current valuation?

Goldman raised the price target for the 4D Molecular Therapeutics Inc (NASDAQ:FDMT) stock to “a Buy”. The rating was released on February 07, 2024, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Overweight, with a price target set at $32. The stock was upgraded by Leerink Partners, who disclosed […]

What’s best: jumping in or staying out? 4D Molecular Therapeutics Inc (FDMT) Stock

Goldman raised the price target for the 4D Molecular Therapeutics Inc (NASDAQ:FDMT) stock to “a Buy”. The rating was released on February 07, 2024, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Overweight, with a price target set at $32. The stock was upgraded by Leerink Partners, who disclosed […]

The idea of catching 4D Molecular Therapeutics Inc (FDMT) Stock might be a good one

Goldman raised the price target for the 4D Molecular Therapeutics Inc (NASDAQ:FDMT) stock to “a Buy”. The rating was released on February 07, 2024, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Overweight, with a price target set at $32. The stock was upgraded by Leerink Partners, who disclosed […]

Are Options A Good Investment Right Now? 4D Molecular Therapeutics Inc (FDMT) Stock

Goldman raised the price target for the 4D Molecular Therapeutics Inc (NASDAQ:FDMT) stock to “a Buy”. The rating was released on February 07, 2024, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Overweight, with a price target set at $32. The stock was upgraded by Leerink Partners, who disclosed […]

4D Molecular Therapeutics Inc (NASDAQ:FDMT) Stock is trading Higher 62.55% From 200-Day SMA

Goldman raised the price target for the 4D Molecular Therapeutics Inc (NASDAQ:FDMT) stock to “a Buy”. The rating was released on February 07, 2024, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]

Growing at an Unbelievable Rate: 4D Molecular Therapeutics Inc (FDMT) Stock

Goldman raised the price target for the 4D Molecular Therapeutics Inc (NASDAQ:FDMT) stock to “a Buy”. The rating was released on February 07, 2024, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]